C.I. Medical Co.,Ltd. (TSE:3540) agreed to acquire 51% stake in TDS Corporation from Tadashi Tsuji on August 30, 2022. TDS Corporation Fiscal year ending May 2022 sales volume is ¥540 million yen, Total Assets ¥288 million, Operating Income ¥28 million, and Net Income ¥33 million. Stock transfer execution date September 5, 2022 (planned).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,930 JPY | -1.13% | +0.26% | -6.43% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.43% | 250M | |
+11.84% | 27.79B | |
-32.98% | 2.98B | |
-15.97% | 2.52B | |
+11.90% | 2.34B | |
-1.11% | 1.91B | |
-13.37% | 1.83B | |
-7.78% | 1.39B | |
-0.38% | 1.27B | |
+4.01% | 1.13B |
- Stock Market
- Equities
- 3540 Stock
- News C.I. Medical Co.,Ltd.
- C.I. Medical Co.,Ltd. agreed to acquire 51% stake in TDS Corporation from Tadashi Tsuji.